SweTree Technologies rights issue fully subscribed

SweTree Technologies AB has completed a rights issue, where the subscription period of the preferential rights issue was completed on November 30, 2019. Including shareholder contributions, the company will receive a total of SEK 15 million.

When the rights issue has been registered with the Swedish Companies Registration Office, the total number of shares in SweTree Technologies amounts to 3,085,791. The share capital is increased by SEK 125,000 and, after the rights issue, amounts to SEK 3,085,791.

The rights issue is being implemented to strengthen the company, among other things, for the large investment that is now being made in the development and construction of a pilot plant for industrially automated production of forest plants, based on somatic embryogenesis. “The goal of the pilot plant is to obtain decision basis for a first full-scale commercial plant with a capacity of 20 million spruce plants per year”, says Christofer Rhén, CEO of SweTree Technologies.

For further information, please contact: Christofer Rhén, CEO of SweTree Technologies, phone +46 (0)90-695 8901

***********************************************************************
About SweTree Technologies SweTree Technologies is a forest biotech company that develops and sells technology for productivity and performance improvement of trees. Customers are both forest companies and biomass-related industries. The vision is to be a world-leading developer of new technology based on biological excellence with customers all over the world. swetree.com

Umeå, February 24, 2020

SweTree Technologies rights issue fully subscribed

SweTree Technologies AB has completed a rights issue, where the subscription period of the preferential rights issue was completed on November 30, 2019. Including shareholder contributions, the company will receive a total of SEK 15 million.

When the rights issue has been registered with the Swedish Companies Registration Office, the total number of shares in SweTree Technologies amounts to 3,085,791. The share capital is increased by SEK 125,000 and, after the rights issue, amounts to SEK 3,085,791.

The rights issue is being implemented to strengthen the company, among other things, for the large investment that is now being made in the development and construction of a pilot plant for industrially automated production of forest plants, based on somatic embryogenesis. “The goal of the pilot plant is to obtain decision basis for a first full-scale commercial plant with a capacity of 20 million spruce plants per year”, says Christofer Rhén, CEO of SweTree Technologies.

For further information, please contact:
Christofer Rhén, CEO of SweTree Technologies, phone +46 (0)90-695 8901

 

***********************************************************************
About SweTree Technologies SweTree Technologies is a forest biotech company that develops and sells technology for productivity and performance improvement of trees. Customers are both forest companies and biomass-related industries. The vision is to be a world-leading developer of new technology based on biological excellence with customers all over the world. swetree.com

Umeå, February 24, 2020